Related Experiment Video
Updated: Jun 8, 2026

In Vitro Assays to Assess Blood-brain Barrier Mesh-like Vessel Formation and Disruption
Published on: June 20, 2017
Angiotensin II induced cerebral microvascular inflammation and increased blood-brain barrier permeability via
1Department of Physiology, Temple University School of Medicine, Philadelphia, PA, USA.
Abstract:
Although hypertension has been implicated in the pathogenesis of vascular disease, its role in inflammatory responses, especially in brain, remains unclear. In this study we found key mechanisms by which angiotensin II (AngII) mediates cerebral microvascular inflammation. C57BL/6 male mice were subjected to slow-pressor dose of AngII infusion using osmotic mini-pumps at a rate of 400 ng/kg/min for 14 days. Vascular inflammation in the brain was evaluated by analysis of leukocyte-endothelial interaction and blood-brain barrier (BBB) permeability. Results from intravital microscopy of pial vessels in vivo, revealed a 4.2 fold (P<0.05, compared to vehicle) increase in leukocyte adhesion on day 4 of AngII infusion. This effect persisted through day 14 of AngII infusion, which resulted in a 2.6 fold (P<0.01, compared to vehicle) increase in leukocyte adhesion. Furthermore, evaluation of BBB permeability by Evans Blue extravasation showed that Ang II significantly affected the BBB, inducing 3.8 times (P<0.05, compared to vehicle) higher permeability. Previously we reported that AngII mediated hypertension promotes oxidative stress in the vasculature. Thus, we used the superoxide scavenger; 4-hydroxy-TEMPO (Tempol) to determine whether AngII via oxidative stress could contribute to higher leukocyte adhesion and increased BBB permeability. Tempol was given via drinking water (2 mmol) on day 4th following Ang II infusion, since oxidative stress increases in this model on day 4. Treatment with Tempol significantly attenuated the increased leukocyte/endothelial interactions and protected the BBB integrity on day 14 of AngII infusion. In conclusion, AngII via oxidative stress increases cerebral microvasculature inflammation and leads to greater immune-endothelial interaction and higher BBB permeability. This finding may open new avenues for the management of nervous system pathology involving cerebrovascular inflammation.
Insights
Hypertension mediated by angiotensin II (AngII) increases brain inflammation and blood-brain barrier permeability via oxidative stress. Antioxidant treatment attenuated these effects, suggesting new therapeutic targets for neurological conditions.
Area of Science:
- Neuroscience
- Cardiovascular Science
- Immunology
Background:
- Hypertension is linked to vascular disease, but its role in brain inflammation is not fully understood.
- Angiotensin II (AngII) is a key mediator in hypertension and vascular responses.
Purpose of the Study:
- To investigate the mechanisms by which AngII induces cerebral microvascular inflammation.
- To determine the role of oxidative stress in AngII-mediated neuroinflammation and blood-brain barrier (BBB) disruption.
Main Methods:
- Angiotensin II (AngII) infusion in C57BL/6 male mice to induce hypertension.
- Intravital microscopy to assess leukocyte-endothelial interactions in pial vessels.
- Evans Blue extravasation to measure blood-brain barrier (BBB) permeability.
- Administration of the superoxide scavenger 4-hydroxy-TEMPO (Tempol) to evaluate its protective effects.
Main Results:
- AngII infusion significantly increased leukocyte adhesion in cerebral microvasculature.
- AngII infusion markedly elevated blood-brain barrier (BBB) permeability.
- Treatment with Tempol attenuated leukocyte adhesion and protected BBB integrity.
- Oxidative stress was identified as a key mediator in AngII-induced neuroinflammation.
Conclusions:
- Angiotensin II (AngII) exacerbates cerebral microvascular inflammation and BBB permeability through oxidative stress.
- Targeting oxidative stress may offer a therapeutic strategy for neurological disorders involving cerebrovascular inflammation.
Related Concept Videos
Cerebral Edema ll: Pathophysiology
Hypertension II: Pathophysiology
Bacterial Meningitis II: Pathophysiology
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Hemorrhagic Stroke ll: Pathophysiology

